SCR-LIP-000593 · Claim · machine-readable JSON →

A positive family history is frequently reported among people with lipedema, though reported frequencies vary widely.

General proposition consolidated from 12 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
10 source(s) · by Amato
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20122026Lipedema: an overview of its clinical manifestations, diagnosis and treatment of the disproportional fatty deposition syndrome - systematic review (2012) · consistentLipedema: A Review of the Literature (2015) · contextualNew Insights on Lipedema: The Enigmatic Disease of the Peripheral Fat — Bauer et al. (2019) · consistentObservational Study on a Large Italian Population with Lipedema: Biochemical and Hormonal Profile, Anatomical and Clinical Evaluation, Self-Reported History — Patton et al. (2024) · consistentCharacteristics and Clinical Features of Patients with Lipedema in Saudi Arabia: A Cross-sectional Comprehensive Assessment — Alosaimi et al. (2024) · consistentClinical characteristics, comorbidities, and correlation with advanced lipedema stages: A retrospective study from a Swiss referral centre — Luta et al. (2025) · consistentUnraveling lipedema: comprehensive insights and the path to future discoveries — Faria et al. (2025) · consistentBrazilian Consensus Statement on Lipedema using the Delphi methodology — Amato et al. (2025) · contextualLipedema and obesity: A narrative review and treatment protocol. — Rathod S, Pouwels S, Schmidt J. (2026) · consistentLipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) · consistent

Evidence (10)

Context (PECO)

PopulationItalian women with lower limb lipedema, stages 1–3
Conditionlipedema
Exposurelipedema diagnosis and clinical characterization
Comparatorgeneral population prevalence estimates
Outcomecomorbidity prevalence (vitamin D insufficiency, CVD, dyslipidemia, depression, autoimmune thyroiditis, PCOS)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log